These results showed that in contrast to breast cancer cells, LACTB’s differentiation-inducing potential is, in the context of ovary cancer models, manifested through induction of EMT instead of influencing the PISD enzyme and lipid metabolism. This evidence concerns the gene LACTB and breast carcinoma.